Second‐line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild‐type KRAS

The goal of the present study was to compare the efficacy of the combination of cetuximab and irinotecan to the combination of oxaliplatin and fluoropyrimidines as second‐line chemotherapy in patients with irinotecan‐refractory and oxaliplatin‐naïve metastatic colorectal cancer (mCRC) harboring wild...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Hong, Yong Sang, Kim, Hwa Jung, Park, Seong Joon, Kim, Kyu‐Pyo, Lee, Jae‐Lyun, Park, Jin Hong, Kim, Jong Hoon, Lim, Seok‐Byung, Yu, Chang Sik, Kim, Jin Cheon, Baek, Ji Yeon, Kim, Sun Young, Kim, Tae Won
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2013
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657158/
https://ncbi.nlm.nih.gov/pubmed/23298313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados